A reduction in public funding for fertility treatment - an econometric analysis of access to treatment and savings to government

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Almost all assisted reproductive technology (ART) and intrauterine insemination (IUI) treatments performed in Australia are subsidized through the Australian Government’s universal insurance scheme, Medicare. In 2010 restrictions on the amount Medicare paid in benefits for these treatments were introduced, increasing patient out-of-pocket payments for fresh and frozen embryo ART cycles and IUI. The aim of this study was to evaluate the impact of the policy on access to treatment, savings in Medicare benefits and the number of ART conceived children not born.

This publication has 17 references indexed in Scilit: